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ABSTRACT
Exposure dose rate to the tumor and surrounding cells during neutron beam irradiation in Boron Neutron Capture 
Therapy (BNCT) comes not only from heavy charged particles produced from the 10B(n,α)7Li nuclear reaction, but also 
from neutron-induced reactions with other biological elements in living tissue, as well as from gamma rays leaked from 
the reactor core. At Dalat Research Reactor, Vietnam, the neutron and gamma dose rate distribution inside a water 
phantom were measured by using activation method and Thermoluminescent Dosimeter (TLD) detector, respectively. 
The results showed that effective thermal neutron dose rate along the center line of the water phantom had a maximum 
value of 479 mSv h-1 at 1 cm in phantom and then decreases rapidly to 4.87 mSv h-1 at 10 cm. The gamma dose rate 
along the center line of the water phantom also reach its maximum of 4.31 mSv h-1 at 1 cm depth and decreases to 1.16 
mSv h-1 at 10 cm position. The maximum biological tumor dose rate was 1.74 Gy-eq h-1, not high enough to satisfy the 
treatment requirement of brain tumors. However, the results of this work are important in supporting of BNCT study in 
the upcoming stages at Dalat Research Reactor.
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ABSTRAK
Kadar dos pendedahan kepada tumor dan sel sekitarnya semasa pancaran sinaran neutron dalam Terapi Boron Neutron 
Tertawan (BNCT) datang bukan sahaja daripada zarah berat bercas yang dihasilkan daripada tindak balas nuklear 
10B(n,α)7Li, tetapi juga daripada tindak balas neutron-teraruh daripada unsur biologi lain dalam tisu hidup, selain 
daripada sinar gama yang bocor daripada teras reaktor. Di Reaktor Penyelidikan Dalat, Vietnam, kadar pengagihan 
dos neutron dan gama dalam fantom air diukur masing-masing menggunakan kaedah pengaktifan dan pengesan 
Thermoluminescent Dosimeter (TLD). Keputusan menunjukkan bahawa kadar dos haba neutron yang berkesan sepanjang 
garis tengah fantom air mempunyai nilai maksimum 479 mSv h-1 pada 1 cm dalam phantom dan kemudian menurun 
dengan pantas kepada 4.87 mSv h-1 pada 10 cm. Kadar dos gama sepanjang garis tengah fantom air juga mencapai 
tahap maksimum 4.31 mSv h-1 pada kedalaman 1 cm dan menurun ke 1.16 mSv h-1 pada kedudukan 10 cm. Kadar dos 
maksimum tumor biologi adalah 1.74 Gy-eq h-1 namun tidak cukup tinggi untuk memenuhi keperluan rawatan tumor 
otak. Walau bagaimanapun, keputusan kajian ini adalah penting dalam menyokong pengajian BNCT pada peringkat akan 
datang di Reaktor Penyelidikan Dalat.
Kata kunci: BNCT; fantom air; fluks haba neutron; kadar dos; pengesan TLD
INTRODUCTION
Boron Neutron Capture Therapy (BNCT) is a very effective 
cancer treatment technique for several types of brain 
tumor (Dao-wen et al. 2012; Marashi 2000; Perks et al. 
1988). This technique is based on the bombardment of 
Boron with low energy thermal neutron that yields alpha 
particles (4He) and recoiling lithium nuclei (7Li). These 
charged particles have high kinetic energy to kill tumor 
cells (Bortolussi & Altieri 2007; Dao-wen et al. 2012; 
Perks et al. 1988), their short ranges in matters reduce the 
damage to healthy tissues surrounding the tumor. However, 
healthy cells are damaged during neutron beam irradiation. 
This side effect comes not only from products generated 
from other neutron-induced reactions with elements in 
living tissue, but also from gamma rays leaking from the 
reactor core (Takada et al. 2014). In general, the dose rate 
in both tumor and healthy tissue are mainly subjected to the 
level of the thermal neutron flux. The gamma dose rate is 
mainly produced from the 1H(n,γ)2H reaction (Sauerwein 
et al. 2012). Determination of neutron and gamma dose 
rate is an important issue in BNCT to ensure the efficacy of 
the treatment and safety for both patients and operators.
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 In general, the magnitude of neutrons flux for a 
successful BNCT treatment should be in the order of 109-
1012 n cm-2 s-1 (Akan et al. 2015). To achieve this neutron 
flux, accelerators or research reactors are employed. In 
some cases, research reactors were modified to provide 
such a high neutron flux. Particularly, TRIGA MARK II 
reactor was utilized due to many advantages presented 
elsewhere (Whittemore 1992), for instance, TRIGA MARK 
II reactor of the Istanbul Technical University (IAEA 
2016), J. Stefan TRIGA MARK-II reactor at J. Stefan 
Institute in Slovenia (Maučec 2001), TRIGA reactor of 
the University of Mainz, Germany (Nagels et al. 2009), 
TRIGA Mushashi reactor in Japan (Matsumoto 1996) and 
TRIGA reactor of the University of Pavia-Italy (Bortolussi 
et al. 2018) have been used for BNCT study with some 
modifications to the beam port or thermal column. 
 At present, Vietnam has only one research reactor 
- Dalat Research Reactor (DRR) -dedicated to training, 
radioisotope production, neutron activation analysis and 
basic research. Up to now, there is no research on BNCT 
in Vietnam. Hence, a pilot project for BNCT study is being 
carried out to examine the capability of developing such 
system at the DRR. As a major target in the first stage of 
the project, the purpose of this study was to determine the 
neutron flux and gamma dose rates in a water phantom 
when irradiated at channel No. 2 of the DRR. The results 
from this study would serve as a basis for future designs 
and development of the BNCT system at the DRR in the 
future which has given many attentions in Vietnam as 
a promising treatment for patients with brain tumor. 
In the near future, a new multi-purposes open - pool 
15 MW research reactor will be constructed in Vietnam 
with a thermal neutron flux of 3.0 × 1014 n cm-2 s-1. As 
designed, there will be 6 horizontal neutron channels 
for fundamental researches including BNCT and PGNAA 
(Nguyen et al. 2012).
MATERIALS AND METHODS
BACKGROUND OF THE DDR CHANNEL NO.2
The DRR is a 500 kW pool-type research reactor using 
light water as both moderator and coolant. Since 2011, 
various neutron filters have been designed, manufactured 
and successfully installed at the horizontal channel No. 
2 of the DRR to produce neutrons with specific energy 
of interest for the purposes of prompt gamma neutron 
activation analysis, neutron radiography and neutron dose 
standardization. Neutron spectrum from channel No. 2 
with silicon-bismuth crystal filter is shown in Figure 1.
EXPERIMENT SETUP USING WATER PHANTOM
In view of thermal neutron utilization, a filter consisted of 
4 cm Bi and 80 cm Si was employed for this experiment. 
Parameters of the thermal neutron beam line right at the 
outer of the horizontal channel No.2 with this type of filter 
is presented in Table 1.
 Due to a similar proton density as that of the normal 
brain tissue, the water phantom has often been used 
to study the thermal neutron flux distribution in BNCT 
(Yamamoto et al. 2002). In this work, a water phantom with 
a rectangular shape of 16 cm × 16 cm × 25 cm was made 
out of 2 mm glass plates and filled with purified water. The 
top cover of the phantom was designed with an array of 
holds for manual insertion and withdrawal of the foils or 
the Thermoluminescent Dosimeter (TLD) detectors. The 
phantom is illustrated in Figure 2.
TABLE 1. Parameters of the thermal neutron beam line at outer of the horizontal 
channel No. 2 of the DRR (Tan & Son 2016)
Thermal neutron flux fth 
(n cm-2 s-1)
Cadmium ratio
RCd (Au)
Filter materials Beam diameter (cm)
1.6 × 106 420 4 cm Bi + 80 cm Si 3
FIGURE. 1 Neutron spectrum from channel No.2 
with Si-Bi crystal filter
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 In order to measure thermal neutron flux in the 
phantom, activation method was used in which foils of 
natural Vanadium element (51V) was used as activation 
foils. The 51V foil has a diameter of 1.27 cm and a purity 
of 99.98%.
IRRADIATION OF THE PHANTOM AND ACTIVITY 
MEASUREMENT OF THE IRRADIATED FOILS
The experimental setup at the neutron beam channel No. 
2 of the DRR are presented in Figure 3.
 The water phantom was irradiated with the thermal 
neutron beam at the horizontal channel No. 2 of the DRR 
after the reactor has operated at 500 kW of power for 24 h. 
Each foil was placed in the phantom at the position 
of interest. Activity of the foil was analyzed with the 
parameters presented in Table 2. 
 A modern gamma-ray spectroscopy (ORTEC DSPEC) 
in compact with a high efficiency and high purity 
Germanium (HPGe) detector was used to measure the 
specific radioactivity of the irradiated foils. The detector 
was calibrated by using a set of standard radioisotope 
sources: 152Eu, 60Co, 57Co, 137Cs, 241Am, 113Sn and 88Y. The 
absolute detection efficiency function for 5 cm distance 
from the end-cap of the detector was also simulated by 
Monte Carlo Geant4 toolkit. The results of simulation 
and measurement of the efficiency curve are illustrated 
in Figure 4.
TABLE 2. Irradiation and measurements details for 51V standard foil by INAA (IAEA 2001)
Nuclide used,
mass (g)
Irradiation time
(s)
Cooling time
(s)
Measurement time
(s)
51V, 0.0925 60-960 176-1800 201-1250
FIGURE 2. The rectangular water phantom
FIGURE 3. Experimental set up at the neutron beam channel 
No.2 of DRR at the DRR
FIGURE 5. The absolute detection efficiency curve of the HPGe 
detector for standard foils at 5 cm from the detector end-cap
 The thermal neutron flux is determined from the 
activity of the Vanadium foil as follows (Akhlaghi et al. 
2013; Tan & Son 2016; Yamamoto et al. 2002),
  (1) 
where C denotes the net counts of the corresponding 
gamma peak; fc is the correction factor for the effects 
of neutron multiple scattering and self-shielding in the 
irradiated foils; λ is the decay constant of the product 
nucleus; ε
γ
 is the detection efficiency of the detector; I
γ
 is 
the intensity of gamma peak of interest; N is the number 
of nuclei in the sample; σ0 is the average thermal neutron 
capture cross section; t1, t2 and t3 are irradiating, cooling 
and measuring times, respectively.
 The decay characteristics of 51V nucleus after capturing 
a thermal neutron is presented in Table 3.
 The TLD detectors have also been used to measure 
gamma dose. Every TLD detector was placed at a specific 
position along the center line of the phantom and was 
irradiated for 1 to 2 h. After that, the TLD detector was 
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TABLE 3. Decay properties of the activation product nuclei 
(Glascock 1998)
Activation 
product
Half-life
(m)
γ-ray
(keV)
Intensity
(%)
52V 3.75 1434.08 100
replaced with a new one and the irradiation process was 
repeated for a similar period of time.
RESULTS AND DISCUSSION
Thermal neutron and gamma flux distribution in the 
water phantom has been measured along the center line. 
Measurements have been carried out at the reactor power 
of 500 kW. A conversion factor with a value of 9.70 × 1010 
n cm-2 s-1 Sv-1 (Kwon et al. 1980) had been used to convert 
thermal neutron flux to the whole body effective neutron 
dose rate. The measured two-dimensional thermal neutron 
flux and whole body effective dose rate distribution of 
neutron are shown in Figure 5.
 The total gamma dose rate at depth positions along the 
inner center-line of the phantom are measured by using the 
TLD dosimeters. The obtained results are shown in Figure 
6.
 The gamma dose rate drops significantly with 
increasing depth in the phantom, decreases from 5.5 to 
0.57 mSv/h over a range of 14 cm. Then, the gamma dose 
rate levels off.
 However, in BNCT, the radiation dose delivered to 
the target organ having the tumor is much significant than 
other organs. Thus, the radiation dose absorbed by the brain 
was estimated separately. In terms of BNCT, the biological 
tumor dose rate in unit of Gy-eq h-1 was defined as (Jarahi 
et al. 2016):
  D = wn × Dtherma l + wg × Dgamma + CBE × DBoron  (2)
where D is the total dose, Dthermal, Dgamma, Dboron are the 
absorbed dose from thermal neutron, gamma and charged 
particles from 10B(n,α)7Li reactions while the wn and wg 
is the radiation weighting factor for thermal neutron and 
gamma, with their values being 3.2 and 1, respectively. 
The Compound Biological Effectiveness (CBE) is equal 
to 3.8 for tumor and 1.3 for normal tissue.
 The absorbed dose from thermal neutrons and 
10B(n,α)7Li reactions in (2) is calculated. The absorbed dose 
component due to thermal neutron (Dthermal) is calculated 
based on Kerma factor for different tissues (kr) as in (3) 
(Singh et al. 2015),
  (3)
FIGURE 6. Gamma dose rate at depth positions along the  
center-line of the phantom
where wi is the percent composition by weight of ith element 
in tissue; and kf(E)i is the kerma factor of ith element in 
tissue. The element components and corresponding wi 
values for brain tissue are suggested in ICRU 46 (White et 
al. 1992) as shown in Table 4. 
FIGURE 5. Two-dimensional thermal neutron (a) flux and 
(b) dose rate distribution in the phantom
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 If the neutron beam is comprised of thermal neutrons 
only, the kerma factor for brain tissues is calculated using 
(3) with element compositions specified in Table 4:
  (4)
 The biologically weighted dose of thermal neutron is 
then calculated using (5).
 Dthermal =  kbrain(0.025eV) × fth.                                                       (5)
where fth is the thermal neutron flux.
 The dose rate from 10B(n,α)7Li reactions (DBoron) is 
calculated using (6) (Horiguchi et al. 2014), 
  DBoron = kB × fth × CB                                                                                      (6)
where kB is the kerma factor for the boron dose which 
was evaluated to be 7.51 × 10-14 Gy cm-2 ppm-1. CB is the 
concentration of 10B in target tissues, having unit of part 
per million. Boron dose presents not only in the tumor but 
in the surrounding normal tissues since the boron transmits 
throughout the body after the boron drug was injected 
to the patient’s blood vein. Because the phantom in this 
experiment contained only pure water so the boron dose in 
this calculation is an evaluation for future work. Normally, 
the boron concentration ratio in tumor and normal tissue 
should be around 3.5 (Goorley et al. 2002; Moghaddasi & 
Bezak 2017). Thus, in this study, the 10B concentration is 
set at 12 ppm in the normal tissue and 42 ppm in the tumor. 
The calculated values of biologically weighted doses using 
(2) and whole body effective dose rate on the center line 
of the phantom were reported in Table 5.
 Figure 7 shows the biologically weighted dose rates 
distribution as functions of depth in the phantom, through 
the center axis of the beam exit. As shown in Figure 8, the 
thermal neutron flux had a maximum value at 1 cm depth 
in the phantom, consequently the thermal neutron dose 
rate also reaches its maximum at 1 cm depth, and then 
decreases rapidly. The boron dose distribution also had 
similar behavior, with the dose in the tumor accounting for 
the majority of the dose received during neutron irradiation. 
In contrast, thermal neutron, gamma and boron dose in 
normal tissues contribute an insignificant amount to the 
total dose within the target organ. The maximum achieved 
value of biological tumor dose rate was 8.04 × 10-1 Gy-eq 
h-1. 
 The dose rates in the phantom of this research has a 
similar shape with those in the work of Bavarnegin et al. 
(2016). However, the total biological tumor dose rates in 
this research is much lower, namely 8.04 × 10-1 Gy-eq h-1 
compared to 72 Gy-eq h-1. In fact, the thermal neutron flux 
at the channel No. 2 of the DRR is nearly 10 times lower and 
the assumed boron concentration is also lower compared 
to values reported by Bavarnegin et al. (2016).
TABLE 5. The biological weighted dose rate of thermal neutron, the boron dose rates and whole                                                       
body total effective dose rate along the center line of the phantom
Position
Biologically 
weighted dose rate 
of thermal neutron
Biologically 
weighted dose 
rate of gamma
Biologically weighted 
boron dose ratefor 
normal tissues
Biologically 
weighted boron 
dose rate for 
tumor
Total 
biologically 
weighted dose 
rate
Whole body 
effective dose 
rate
(cm) (Gy-eq/h) (Gy-eq/h) (Gy-eq/h) (Gy-eq/h) (Gy-eq/h) (mSv/h)
1
2
3
4
5
6
7
8
10
1.94E-01
1.09E-01
5.75E-02
3.05E-02
1.68E-02
1.02E-02
6.00E-03
3.75E-03
1.52E-03
4.37E-03
3.01E-03
2.73E-03
1.80E-03
1.65E-03
1.64E-03
1.13E-03
1.08E-03
1.16E-03
5.40E-02
3.02E-02
1.60E-02
8.48E-03
4.68E-03
2.82E-03
1.67E-03
1.04E-03
4.21E-04
5.52E-01
3.09E-01
1.64E-01
8.67E-02
4.79E-02
2.89E-02
1.70E-02
1.07E-02
4.31E-03
8.04E-01
4.51E-01
2.40E-01
1.27E-01
7.10E-02
4.36E-02
2.58E-02
1.66E-02
7.41E-03
4.79E+02
2.68E+02
1.43E+02
7.64E+01
4.27E+01
2.65E+01
1.57E+01
1.01E+01
4.87E+00
TABLE 4. Material composition of an adult whole brain 
Composition H C N O Na P S Cl K
Weight 
percentage 10.7 14.5 2.2 71.2 0.2 0.4 0.2 0.3 0.3
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CONCLUSION
The thermal neutron flux distribution in the water phantom 
irradiated at Channel No. 2 of the DRR was determined by 
using activation method with 51V foils as activation foils. 
The results showed that thermal neutron dose rate along 
center line of the water phantom had a maximum value 
479 mSv h-1 at 1 cm in phantom and then decreases rapidly 
to 4.87 mSv h-1 at 10 cm. The gamma dose is insignificant 
due to its low magnitude. The current configuration of 
channel No. 2 at the DRR is not able to be used for BNCT 
due to the low biological dose rate, with its maximum value 
being 8.04 × 10-1 Gy-eq h-1 at 1 cm depth in the phantom. 
However, the results of this work are still important for 
future BNCT study at DRR, especially when a new reactor 
with much higher power is to be built.
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